BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21879835)

  • 1. Adrenal lesions in patients with extra-adrenal malignancy - benign or malignant?
    Hammarstedt L; Muth A; Sigurjónsdóttir HÁ; Almqvist E; Wängberg B; Hellström M;
    Acta Oncol; 2012 Feb; 51(2):215-21. PubMed ID: 21879835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidental indeterminate adrenal mass on CT (> 10 H) in patients without cancer: is further imaging necessary? Follow-up of 321 consecutive indeterminate adrenal masses.
    Song JH; Chaudhry FS; Mayo-Smith WW
    AJR Am J Roentgenol; 2007 Nov; 189(5):1119-23. PubMed ID: 17954649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiologic evaluation of incidentally discovered adrenal masses.
    Willatt JM; Francis IR
    Am Fam Physician; 2010 Jun; 81(11):1361-6. PubMed ID: 20521756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal lesion frequency: A prospective, cross-sectional CT study in a defined region, including systematic re-evaluation.
    Hammarstedt L; Muth A; Wängberg B; Björneld L; Sigurjónsdóttir HA; Götherström G; Almqvist E; Widell H; Carlsson S; Ander S; Hellström M;
    Acta Radiol; 2010 Dec; 51(10):1149-56. PubMed ID: 20969508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cohort study of patients with adrenal lesions discovered incidentally.
    Muth A; Hammarstedt L; Hellström M; Sigurjónsdóttir HÁ; Almqvist E; Wängberg B;
    Br J Surg; 2011 Oct; 98(10):1383-91. PubMed ID: 21618498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
    Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
    Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of solid adrenal masses using adrenocortical scintigraphy.
    Dominguez-Gadea L; Diez L; Bas C; Crespo A
    Clin Radiol; 1994 Nov; 49(11):796-9. PubMed ID: 7955847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The indeterminate adrenal lesion.
    Sahdev A; Willatt J; Francis IR; Reznek RH
    Cancer Imaging; 2010 Mar; 10(1):102-13. PubMed ID: 20299300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adrenal mass: correlation of histopathology with imaging.
    Yip L; Tublin ME; Falcone JA; Nordman CR; Stang MT; Ogilvie JB; Carty SE; Yim JH
    Ann Surg Oncol; 2010 Mar; 17(3):846-52. PubMed ID: 19960266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of relative wash-in ratio of adrenal lesions at early biphasic CT.
    Foti G; Faccioli N; Manfredi R; Mantovani W; Mucelli RP
    AJR Am J Roentgenol; 2010 Jun; 194(6):1484-91. PubMed ID: 20489087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Computerized tomography findings score in the differentiation of adrenal tumors in patients with extra-adrenal malignomas].
    Gufler H; Buitrago-Tellez CH; Laubenberger J; Tanyü MO; Mundinger A
    Rofo; 1996 Aug; 165(2):118-22. PubMed ID: 8924662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of adrenal incidentaloma in patients with a history of malignancy.
    Frilling A; Tecklenborg K; Weber F; Kühl H; Müller S; Stamatis G; Broelsch C
    Surgery; 2004 Dec; 136(6):1289-96. PubMed ID: 15657589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy.
    Song JH; Chaudhry FS; Mayo-Smith WW
    AJR Am J Roentgenol; 2008 May; 190(5):1163-8. PubMed ID: 18430826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience.
    Blake MA; Slattery JM; Kalra MK; Halpern EF; Fischman AJ; Mueller PR; Boland GW
    Radiology; 2006 Mar; 238(3):970-7. PubMed ID: 16505394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical features of seven adult adrenal ganglioneuromas.
    Rondeau G; Nolet S; Latour M; Braschi S; Gaboury L; Lacroix A; Panzini B; Arjane P; Cohade C; Bourdeau I
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3118-25. PubMed ID: 20427489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay.
    Blake MA; Kalra MK; Sweeney AT; Lucey BC; Maher MM; Sahani DV; Halpern EF; Mueller PR; Hahn PF; Boland GW
    Radiology; 2006 Feb; 238(2):578-85. PubMed ID: 16371582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-energy CT for characterization of adrenal nodules: initial experience.
    Gupta RT; Ho LM; Marin D; Boll DT; Barnhart HX; Nelson RC
    AJR Am J Roentgenol; 2010 Jun; 194(6):1479-83. PubMed ID: 20489086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiologic-pathologic correlation in extra-adrenal myelolipoma.
    Itani M; Wasnik AP; Platt JF
    Abdom Imaging; 2014 Apr; 39(2):394-7. PubMed ID: 24370965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants for malignancy in surgically treated adrenal lesions.
    Wright L; Nordenström E; Almquist M
    Langenbecks Arch Surg; 2012 Feb; 397(2):217-23. PubMed ID: 21935703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.